European Congress of Pathology
Thank you for visiting our booth at ECP 2018 conference
If you did not have a chance to visit our booth or symposium or would like access to the scientific talk presented at the conference, here is an opportunity to download all the information you need.
Advances in our knowledge about tumour evolution, resistance development mechanisms and immuno-oncology, are leading towards changing the standard of care in many types of cancer. Continuous new biomarker implementation is becoming a norm for pathology laboratories and standardisation of the tests is a key requirement.
See the results thought leaders shared of their recent studies focusing on:
How new biomarkers like mutational burden and TCR sequencing may enhance immunotherapies studies
The most recent results on tumour mutation burden biomarker standardisation studies
The implementation of liquid biopsy next generation sequencing assays and the impact on real case studies
For Research Use Only. Not for use in diagnostic procedures.